Loading insider details...
Latest Form 4 (Nov 4, 2026): Sale of 40,000 RXRX shares, $155.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 40,000 | $155.2K |
| Oct 7, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 50,000 | $242.0K |
| Sep 2, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 30,000 | $100.2K |
| Aug 6, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 30,000 | $97.5K |
| Jul 9, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 40,000 | $158.5K |
| Jun 22, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 88,424 | n/a |
| Jun 4, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 30,000 | $110.4K |
| May 7, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 30,000 | $105.6K |
| Apr 8, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 30,000 | $93.0K |
| Mar 4, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 170,000 | $588.2K |